HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Hybrid revascularisation in a patient with multivessel and left main coronary disease].

Abstract
According to current guidelines surgical revascularisation is a gold standard of treatment in patients with multivessel and left main coronary disease. Hybrid revascularisation, in two stages: first - minimally invasive direct coronary artery bypass grafting procedure with left internal mammary artery conduit to left anterior descending artery and second stage - percutaneus coronary intervention with drug eluting stent in non-left anterior descending vessels may be safe and effective alternative in patients with multivessel and left main coronary disease.
AuthorsMateusz Tajstra, Mariusz Gąsior, Krzysztof Filipiak, Michał Zembala, Tomasz Hrapkowicz, Michał Hawranek, Anna Kazik, Lech Poloński, Marian Zembala
JournalKardiologia polska (Kardiol Pol) Vol. 69 Issue 3 Pg. 270-3; discussion 274 ( 2011) ISSN: 0022-9032 [Print] Poland
Vernacular TitleRewaskularyzacja hybrydowa u pacjenta z wielonaczyniową chorobą wieńcową z zajęciem pnia lewej tętnicy wieńcowej.
PMID21432800 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Angioplasty, Balloon, Coronary
  • Coronary Artery Disease (surgery, therapy)
  • Humans
  • Internal Mammary-Coronary Artery Anastomosis
  • Male
  • Middle Aged
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: